The University of Chicago Header Logo

Connection

Andrew Aronsohn to Antiviral Agents

Back to Details
This is a "connection" page, showing publications Andrew Aronsohn has written about Antiviral Agents.
Andrew Aronsohn
Connection Strength
4.403
Antiviral Agents
  1. Pay It Forward: Building Capacity to Treat Hepatitis C by Training Our Own Residents. Hepatology. 2018 11; 68(5):2004-2007.
    View in: PubMed
    Score: 0.497
  2. Overcoming injustice: A roadmap to improve access to hepatitis C virus therapy for our medicaid patients. Hepatology. 2017 05; 65(5):1735-1740.
    View in: PubMed
    Score: 0.447
  3. Current Management of Chronic Hepatitis B and C in Chronic Kidney Disease. Adv Chronic Kidney Dis. 2015 Sep; 22(5):352-60.
    View in: PubMed
    Score: 0.401
  4. Interferon-combination strategies for the treatment of chronic hepatitis C. Semin Liver Dis. 2014 Feb; 34(1):30-6.
    View in: PubMed
    Score: 0.365
  5. Preparing for the uncertain yet inevitable: off-label combinations of antiviral agents in hepatitis C virus. Hepatology. 2014 May; 59(5):1688-91.
    View in: PubMed
    Score: 0.361
  6. Expanding access to hepatitis C virus care: a call to deconstruct individualized therapy. Hepatology. 2014 Jan; 59(1):13-5.
    View in: PubMed
    Score: 0.352
  7. Impact of age on viral kinetics of peginterferon alfa-2a/ribavirin in chronic hepatitis C: final analysis from the PROPHESYS cohort. J Viral Hepat. 2014 May; 21(5):377-80.
    View in: PubMed
    Score: 0.352
  8. Is the HCV pipeline heading in the right direction? Gastroenterology. 2013 Mar; 144(3):482-5.
    View in: PubMed
    Score: 0.335
  9. Informed deferral: a moral requirement for entry into the hepatitis C virus treatment warehouse. Hepatology. 2012 Nov; 56(5):1591-2.
    View in: PubMed
    Score: 0.329
  10. Distributive justice and the arrival of direct-acting antivirals: who should be first in line? Hepatology. 2011 Jun; 53(6):1789-91.
    View in: PubMed
    Score: 0.299
  11. Long-term outcomes after treatment with interferon and ribavirin in HCV patients. J Clin Gastroenterol. 2009 Aug; 43(7):661-71.
    View in: PubMed
    Score: 0.263
  12. Liver Transplantation of HCV-viremic Donors Into HCV-negative Recipients in the United States: Increasing Frequency With Profound Geographic Variation. Transplantation. 2021 06 01; 105(6):1285-1290.
    View in: PubMed
    Score: 0.149
  13. You Can't Have One Without the Other: Innovation and Ethical Dilemmas in Gastroenterology and Hepatology. Clin Gastroenterol Hepatol. 2021 10; 19(10):2015-2019.
    View in: PubMed
    Score: 0.139
  14. Timing Is Everything: Managing Hepatitis C Virus in Liver Transplant Candidates. Transplantation. 2017 05; 101(5):898-899.
    View in: PubMed
    Score: 0.112
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.